Event Calendar
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
European Health Forum Gastein 2024
This was 3 months ago
LocationHybrid event
The European Health Forum Gastein (EHFG) is a European health policy platform, which aims to provide an inclusive platform for discussions and advancement of health, solidarity and equity in the EU and beyond.
Every year, EHFG’s annual conference brings together leading experts, decision-makers and members of the European public health community. The conference theme of the 2024 edition is 'Shifting sands of health - Democracy, demographics, digitalisation'. Among the speakers are officials from the Commission, European Medicines Agency & WHO.
Please note that this is a paying event for participation on-site. Online participation is offered free of charge.
More information, the detailed programme and registration on the event website.
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Event calendar
36 upcoming events view event calendarDigital, Industry & Space AI, data & cloud Deployment: Best use of technologies
BDTI Pilot Showcase: Presenting data-driven solutions in action
Security AI, data & cloud Cybersecurity Defence Space
Info day on the DEFRA call 2025
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
